Media Summary: Although curative therapies have transformed "No One Waits: Community-Based Approaches to The Texas Liver Institute staff goes to The Alamo to query the people of San Antonio about

Hepatitis C Jennifer Price Md Phd - Detailed Analysis & Overview

Although curative therapies have transformed "No One Waits: Community-Based Approaches to The Texas Liver Institute staff goes to The Alamo to query the people of San Antonio about Professor Graham Foster talks about the main advances that we can expect to see in the management of For our 2025 Poster Competition, Jeffrey Lowell In part one, Jim Wilson, RPh, MBA, president of WilsonRx, discusses his initial diagnosis with

Check out this preview of Interesting Cases: Difficult to Treat In part six, Jim Wilson, RPh, MBA, president of WilsonRx, discusses how

Photo Gallery

Hepatitis C - Jennifer Price, MD,  PhD
Hepatitis C: Are We There Yet? Updates and the Road Ahead
Dr. Jennifer Price | Interventions that Address Systems & Structures to Reduce HCV Disparities
Hepatitis C
The New Era of Hep C Cure: Who Should Be Treated?
Is an HCV cure rate of 100 percent realistic?
How Much Do You Know About Hepatitis C?
Norah Terrault, MPH, MD: Managing DAA Failures When Treating Hepatitis C Virus Infections
Medical Minute - HIV and Hepatitis C
Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable
Are there any special populations in treatment of HCV left? | Douglas Dieterich, MD
Treatment of Hepatitis C Pre-transplant: Pros vs. Cons
View Detailed Profile
Hepatitis C - Jennifer Price, MD,  PhD

Hepatitis C - Jennifer Price, MD, PhD

Going to introduce um so Dr

Hepatitis C: Are We There Yet? Updates and the Road Ahead

Hepatitis C: Are We There Yet? Updates and the Road Ahead

Although curative therapies have transformed

Dr. Jennifer Price | Interventions that Address Systems & Structures to Reduce HCV Disparities

Dr. Jennifer Price | Interventions that Address Systems & Structures to Reduce HCV Disparities

"No One Waits: Community-Based Approaches to

Hepatitis C

Hepatitis C

By Dr.

The New Era of Hep C Cure: Who Should Be Treated?

The New Era of Hep C Cure: Who Should Be Treated?

Visit: http://www.uctv.tv/)

Is an HCV cure rate of 100 percent realistic?

Is an HCV cure rate of 100 percent realistic?

David E. Bernstein,

How Much Do You Know About Hepatitis C?

How Much Do You Know About Hepatitis C?

The Texas Liver Institute staff goes to The Alamo to query the people of San Antonio about

Norah Terrault, MPH, MD: Managing DAA Failures When Treating Hepatitis C Virus Infections

Norah Terrault, MPH, MD: Managing DAA Failures When Treating Hepatitis C Virus Infections

Norah Terrault, MPH,

Medical Minute - HIV and Hepatitis C

Medical Minute - HIV and Hepatitis C

Dr. Talal gives us a run down on HIV and

Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable

Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable

Radha K. Dhiman

Are there any special populations in treatment of HCV left? | Douglas Dieterich, MD

Are there any special populations in treatment of HCV left? | Douglas Dieterich, MD

Speaker: Douglas Dieterich,

Treatment of Hepatitis C Pre-transplant: Pros vs. Cons

Treatment of Hepatitis C Pre-transplant: Pros vs. Cons

Visit: http://www.uctv.tv/)

VHC 2013 Professor Graham Foster - Hepatitis C management

VHC 2013 Professor Graham Foster - Hepatitis C management

Professor Graham Foster talks about the main advances that we can expect to see in the management of

Late Breaking Session on Hepatitis C Virus -- The Liver Meeting 2013

Late Breaking Session on Hepatitis C Virus -- The Liver Meeting 2013

AASLD TV interviewed Donald Jensen,

Hepatitis C Has a Cure! So, What Are My Options? Jeffrey Lowell MD PhD

Hepatitis C Has a Cure! So, What Are My Options? Jeffrey Lowell MD PhD

For our 2025 Poster Competition, Jeffrey Lowell

Hepatitis C Patient Journey: Diagnosis

Hepatitis C Patient Journey: Diagnosis

In part one, Jim Wilson, RPh, MBA, president of WilsonRx, discusses his initial diagnosis with

HCV Pathogenesis - The Liver Meeting 2013

HCV Pathogenesis - The Liver Meeting 2013

Bruce Bacon,

The Discovery of a Hepatitis C Cure

The Discovery of a Hepatitis C Cure

Michael Sofia,

Interesting Cases: Difficult to Treat Hepatitis C Virus by Hugo E. Vargas, MD | Preview

Interesting Cases: Difficult to Treat Hepatitis C Virus by Hugo E. Vargas, MD | Preview

Check out this preview of Interesting Cases: Difficult to Treat

Hepatitis C Patient Journey: The Impact on Quality of Life

Hepatitis C Patient Journey: The Impact on Quality of Life

In part six, Jim Wilson, RPh, MBA, president of WilsonRx, discusses how